D
Madrigal Pharmaceuticals, Inc. MDGL
$424.00 $11.772.85% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 1,353.76% -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue 1,353.76% -- -- -- --
Cost of Revenue 1,325.31% -- -- -- --
Gross Profit 1,355.06% -- -- -- --
SG&A Expenses 86.69% 107.77% 203.47% 290.04% 490.91%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 46.75% 42.44% 45.35% 81.13% 104.95%
Operating Income 70.96% 47.83% 42.82% -18.03% -88.01%
Income Before Tax 72.18% 50.36% 47.04% -8.33% -77.12%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 72.18% 50.36% 47.04% -8.33% -77.12%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 72.18% 50.36% 47.04% -8.33% -77.12%
EBIT 70.96% 47.83% 42.82% -18.03% -88.01%
EBITDA 71.14% 48.03% 43.07% -17.89% -87.98%
EPS Basic 73.19% 55.06% 52.28% 7.96% -51.54%
Normalized Basic EPS 73.19% 55.06% 52.28% 7.96% -51.54%
EPS Diluted 73.19% 55.06% 52.28% 7.96% -51.54%
Normalized Diluted EPS 73.19% 55.06% 52.28% 7.96% -51.54%
Average Basic Shares Outstanding 3.76% 10.45% 10.97% 17.70% 16.88%
Average Diluted Shares Outstanding 3.76% 10.45% 10.97% 17.70% 16.88%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --